Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein - Institut Pasteur Access content directly
Journal Articles Cell Year : 2020

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Abstract

The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans. We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs. We determined cryo-EM structures of the SARS-CoV-2 S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry. Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.

Dates and versions

pasteur-02546518 , version 1 (18-04-2020)

Identifiers

Cite

Alexandra Walls, Young-Jun Park, M. Alejandra Tortorici, Abigail Wall, Andrew Mcguire, et al.. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 2020, 181 (2), pp.281-292.e6. ⟨10.1016/j.cell.2020.02.058⟩. ⟨pasteur-02546518⟩
129 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More